306 related articles for article (PubMed ID: 11592528)
1. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
2. Role of alpha-2 agonists in neuroprotection.
Wheeler L; WoldeMussie E; Lai R
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S47-51. PubMed ID: 12852434
[TBL] [Abstract][Full Text] [Related]
3. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.
Wheeler LA; Gil DW; WoldeMussie E
Surv Ophthalmol; 2001 May; 45 Suppl 3():S290-4; discussion S295-6. PubMed ID: 11377451
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
5. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.
Wheeler LA; Lai R; Woldemussie E
Eur J Ophthalmol; 1999; 9 Suppl 1():S17-21. PubMed ID: 10230601
[TBL] [Abstract][Full Text] [Related]
6. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells.
Gao H; Qiao X; Cantor LB; WuDunn D
Arch Ophthalmol; 2002 Jun; 120(6):797-803. PubMed ID: 12049586
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
9. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
10. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
11. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
Cantor LB
Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
[TBL] [Abstract][Full Text] [Related]
12. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
[TBL] [Abstract][Full Text] [Related]
13. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.
Vidal-Sanz M; Lafuente MP; Mayor-Torroglosa S; Aguilera ME; Miralles de Imperial J; Villegas-Pérez MP
Eur J Ophthalmol; 2001; 11 Suppl 2():S36-40. PubMed ID: 11592529
[TBL] [Abstract][Full Text] [Related]
14. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Exp Eye Res; 2007 Feb; 84(2):293-301. PubMed ID: 17113077
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.
Aktaş Z; Gürelik G; Akyürek N; Onol M; Hasanreisoğlu B
Clin Exp Ophthalmol; 2007 Aug; 35(6):527-34. PubMed ID: 17760634
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
[TBL] [Abstract][Full Text] [Related]
18. Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.
Zhou X; Zhang T; Wu J
Exp Eye Res; 2019 Dec; 189():107833. PubMed ID: 31618613
[TBL] [Abstract][Full Text] [Related]
19. Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists.
Vidal-Sanz M; Lafuente MP; Mayor S; de Imperial JM; Villegas-Pérez MP
Surv Ophthalmol; 2001 May; 45 Suppl 3():S261-7; discussion S273-6. PubMed ID: 11377446
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
Lafuente MP; Villegas-Pérez MP; Mayor S; Aguilera ME; Miralles de Imperial J; Vidal-Sanz M
Exp Eye Res; 2002 Feb; 74(2):181-9. PubMed ID: 11950228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
